These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6361561

  • 21. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH.
    N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535
    [Abstract] [Full Text] [Related]

  • 22. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.
    Yilmaz MB, Balbay Y, Caldir V, Ayaz S, Guray Y, Guray U, Korkmaz S.
    Thromb Res; 2005 May 31; 115(1-2):25-9. PubMed ID: 15567449
    [Abstract] [Full Text] [Related]

  • 23. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA.
    J Thorac Cardiovasc Surg; 1994 Apr 31; 107(4):1146-53. PubMed ID: 8159037
    [Abstract] [Full Text] [Related]

  • 24. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N, Wright J, Sturridge M, Pepper J, Magee P, Walesby R, Layton C, Honey M, Balcon R.
    Br Heart J; 1985 Feb 31; 53(2):201-7. PubMed ID: 3881108
    [Abstract] [Full Text] [Related]

  • 25. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI.
    J Am Coll Cardiol; 1994 Nov 01; 24(5):1181-8. PubMed ID: 7930237
    [Abstract] [Full Text] [Related]

  • 26. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial.
    Hartmann JR, McKeever LS, O'Neill WW, White CJ, Whitlow PL, Gilmore PS, Doorey AJ, Galichia JP, Enger EL.
    J Am Coll Cardiol; 1996 Jan 01; 27(1):60-6. PubMed ID: 8522711
    [Abstract] [Full Text] [Related]

  • 27. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G, Pajarón A, Alegría E, Coello I, Cardona M, Fournier JA, Gómez-Recio M, Ruano J, Hidalgo R, Medina A.
    Circulation; 1990 Sep 01; 82(3):765-73. PubMed ID: 2203555
    [Abstract] [Full Text] [Related]

  • 28. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
    Sanz G.
    Thromb Res Suppl; 1990 Sep 01; 12():23-6. PubMed ID: 2082484
    [Abstract] [Full Text] [Related]

  • 29. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
    Rosenthal D, Mittenthal MJ, Ruben DM, Jones DH, Estes JW, Stanton PE, Lamis PA.
    Am Surg; 1987 Sep 01; 53(9):477-81. PubMed ID: 3631756
    [Abstract] [Full Text] [Related]

  • 30. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J, Hillege HL, Kootstra GJ, Ascoop CA, Mulder BJ, Pfisterer M, van Gilst WH, Lie KI.
    Lancet; 1993 Jul 31; 342(8866):257-64. PubMed ID: 8101300
    [Abstract] [Full Text] [Related]

  • 31. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V, Chesebro JH.
    Circulation; 1986 Feb 31; 73(2):227-32. PubMed ID: 3510762
    [Abstract] [Full Text] [Related]

  • 32. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P, Altimiras J, Arís A, Augé JM, Bassons T, Bonal J, Caralps JM, Castellarnau C, Crexells C, Masotti M.
    Eur Heart J; 1989 Feb 31; 10(2):159-67. PubMed ID: 2647494
    [Abstract] [Full Text] [Related]

  • 33. Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts.
    Mayer JE, Lindsay WG, Castaneda W, Nicoloff DM.
    Ann Thorac Surg; 1981 Mar 31; 31(3):204-10. PubMed ID: 7011226
    [Abstract] [Full Text] [Related]

  • 34. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH.
    Thromb Res Suppl; 1990 Mar 31; 12():5-10. PubMed ID: 2082487
    [Abstract] [Full Text] [Related]

  • 35. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
    Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN, Griffith BP.
    J Thorac Cardiovasc Surg; 2006 Jan 31; 131(1):122-30. PubMed ID: 16399303
    [Abstract] [Full Text] [Related]

  • 36. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries.
    Lytle BW, Loop FD, Taylor PC, Goormastic M, Stewart RW, Novoa R, McCarthy P, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1993 Apr 31; 105(4):605-12; discussion 612-4. PubMed ID: 8468995
    [Abstract] [Full Text] [Related]

  • 37. Bridge saphenous vein graft.
    Cheanvechai C, Groves LK, Surakiatchanukul S, Tanaka N, Effler DB, Shirey EK, Sones FM.
    J Thorac Cardiovasc Surg; 1975 Jul 31; 70(1):63-8. PubMed ID: 1080225
    [Abstract] [Full Text] [Related]

  • 38. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G, Heiman F, Lavezzari M, Marubini E.
    Coron Artery Dis; 1998 Jul 31; 9(4):217-22. PubMed ID: 9649928
    [Abstract] [Full Text] [Related]

  • 39. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB, Lotina SI, Kostić DM, Cinara II, Cvetković SD, Stojanov PL, Velimirović DB, Marković MM, Pejkić SA, Vukotić AM.
    Srp Arh Celok Lek; 1997 Jul 31; 125(1-2):24-35. PubMed ID: 17974352
    [Abstract] [Full Text] [Related]

  • 40. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
    Teoh KH, Christakis GT, Weisel RD, Wong PY, Mee AV, Ivanov J, Madonik MM, Levitt DS, Reilly PA, Rosenfeld JM.
    J Thorac Cardiovasc Surg; 1988 Aug 31; 96(2):332-41. PubMed ID: 3398555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.